These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 11375360)

  • 1. A model educational program for people with type 2 diabetes: a cooperative Latin American implementation study (PEDNID-LA).
    Gagliardino JJ; Etchegoyen G;
    Diabetes Care; 2001 Jun; 24(6):1001-7. PubMed ID: 11375360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study.
    Clifford RM; Davis WA; Batty KT; Davis TM;
    Diabetes Care; 2005 Apr; 28(4):771-6. PubMed ID: 15793171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between ethnicity and glycemic control, lipid profiles, and blood pressure during the first 9 years of type 2 diabetes: U.K. Prospective Diabetes Study (UKPDS 55).
    Davis TM; Cull CA; Holman RR;
    Diabetes Care; 2001 Jul; 24(7):1167-74. PubMed ID: 11423497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Microalbuminuria Education Medication and Optimisation (MEMO) study: 4 years follow-up of multifactorial intervention in high-risk individuals with type 2 diabetes.
    Crasto W; Morrison AE; Gray LJ; John E; Jarvis J; Brela J; Khunti K; Troughton J; Lawrence IG; McNally PG; Davies MJ
    Diabet Med; 2020 Feb; 37(2):286-297. PubMed ID: 31505051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of ETC-1002, a novel investigational low-density lipoprotein-cholesterol-lowering therapy for the treatment of patients with hypercholesterolemia and type 2 diabetes mellitus.
    Gutierrez MJ; Rosenberg NL; Macdougall DE; Hanselman JC; Margulies JR; Strange P; Milad MA; McBride SJ; Newton RS
    Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):676-83. PubMed ID: 24385236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study.
    Blonde L; Merilainen M; Karwe V; Raskin P;
    Diabetes Obes Metab; 2009 Jun; 11(6):623-31. PubMed ID: 19515182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes education program for people with type 2 diabetes: An international perspective.
    Rashed OA; Sabbah HA; Younis MZ; Kisa A; Parkash J
    Eval Program Plann; 2016 Jun; 56():64-8. PubMed ID: 27060766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes.
    Abraira C; Colwell JA; Nuttall FQ; Sawin CT; Nagel NJ; Comstock JP; Emanuele NV; Levin SR; Henderson W; Lee HS
    Diabetes Care; 1995 Aug; 18(8):1113-23. PubMed ID: 7587846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Albuminuria and 24-h ambulatory blood pressure in normoalbuminuric and microalbuminuric NIDDM patients. A longitudinal study.
    Nielsen S; Schmitz A; Poulsen PL; Hansen KW; Mogensen CE
    Diabetes Care; 1995 Nov; 18(11):1434-41. PubMed ID: 8722066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing diabetes care regarding cardiovascular targets at general practice level: Direct@GP.
    Wens J; Gerard R; Vandenberghe H
    Prim Care Diabetes; 2011 Apr; 5(1):19-24. PubMed ID: 21030327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ["Diabetes in Germany"(DIG) study. A prospective 4-year-follow-up study on the quality of treatment for type 2 diabetes in daily practice].
    Ott P; Benke I; Stelzer J; Köhler C; Hanefeld M
    Dtsch Med Wochenschr; 2009 Feb; 134(7):291-7. PubMed ID: 19197810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of glycaemic control in type 2 diabetes: favourable changes in blood pressure, total cholesterol and triglycerides, but not in HDL cholesterol, fibrinogen, Von Willebrand factor and (pro)insulin.
    Becker A; van der Does FE; van Hinsbergh VW; Heine RJ; Bouter LM; Stehouwer CD
    Neth J Med; 2003 Apr; 61(4):129-36. PubMed ID: 12852722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients.
    Chow CC; Tsang LW; Sorensen JP; Cockram CS
    Diabetes Care; 1995 Mar; 18(3):307-14. PubMed ID: 7555472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pharmacotherapy follow-up program in patients with type-2 diabetes in community pharmacies in Spain.
    Fornos JA; Andrés NF; Andrés JC; Guerra MM; Egea B
    Pharm World Sci; 2006 Apr; 28(2):65-72. PubMed ID: 16791717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metabolic control and weight loss in patients with obesity and type 2 diabetes mellitus, treated with exenatide].
    Pujante Alarcón P; Hellín Gil MD; Román LM; Ferrer Gómez M; García Zafra MV; Tébar Massó J
    Med Clin (Barc); 2012 Dec; 139(13):572-8. PubMed ID: 22209597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes.
    Farmer AJ; Perera R; Ward A; Heneghan C; Oke J; Barnett AH; Davidson MB; Guerci B; Coates V; Schwedes U; O'Malley S
    BMJ; 2012 Feb; 344():e486. PubMed ID: 22371867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study on the efficacy of pioglitazone in Caucasian and Maori-Polynesian patients with poorly controlled type 2 diabetes.
    Shand B; Scott R; Connolly S; Clarke R; Baker J; Elder P; Frampton C; Yeo J
    Diabetes Obes Metab; 2007 Jul; 9(4):540-7. PubMed ID: 17587396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Costs of therapy of insulin-treated patients with Diabetes mellitus in Germany. Results of the JEVIN trial].
    Schiel R; Müller UA; Stein G
    Med Klin (Munich); 2005 Aug; 100(8):453-61. PubMed ID: 16096726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Group visits improve metabolic control in type 2 diabetes: a 2-year follow-up.
    Trento M; Passera P; Tomalino M; Bajardi M; Pomero F; Allione A; Vaccari P; Molinatti GM; Porta M
    Diabetes Care; 2001 Jun; 24(6):995-1000. PubMed ID: 11375359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.